Email this article Novye Evropeyskie rekomendatsii po vedeniyu patsientov s arterial'noy gipertoniey: mesto sartanov
- Authors: Chazova IE1
-
Affiliations:
- Issue: Vol 5, No 2 (2008)
- Pages: 4-7
- Section: Articles
- URL: https://journals.eco-vector.com/2075-082X/article/view/33037
- DOI: https://doi.org/10.26442/SG33037
- ID: 33037
Cite item
Full Text
Abstract
References
- Guidelines for the management of arterial hypertension. J Hypertension 2007; 25: 1105-87.
- Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998; 20 (4): 671-81.
- Hasford J, Mimran A, Simons WR. A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Human Hypertension 2002; 16 (8): 569-75.
- Parving HH et al. Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345 (12): 870-8.
- Lewis EJ et al. Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345 (12): 851-60.
Supplementary files
